Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Added Value of Automatic Segmentation of Cerebral Gliomas in Multi-Sequence Magnetic Resonance Imaging (MRI)

NCT04674579 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04674579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Added Value of Automatic Segmentation of Cerebral Gliomas in Multi-Sequence Magnetic Resonance Imaging (MRI)
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
April 30, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral glioblastoma